J. King

5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk).

R. DesJarlais, J. Woska, C. Cywin, 2008, Bioorganic & medicinal chemistry letters.

Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors.

Noel S. Wilson, C. Cywin, G. Roth, 2007, Bioorganic & medicinal chemistry letters.

Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.

D. Ryan, G. Roth, M. Kashem, 2008, Bioorganic & medicinal chemistry letters.